Famotidine in the management of schizophrenia

Authors
Citation
Mc. Martinez, Famotidine in the management of schizophrenia, ANN PHARMAC, 33(6), 1999, pp. 742
Citations number
14
Categorie Soggetti
Pharmacology
Journal title
ANNALS OF PHARMACOTHERAPY
ISSN journal
10600280 → ACNP
Volume
33
Issue
6
Year of publication
1999
Database
ISI
SICI code
1060-0280(199906)33:6<742:FITMOS>2.0.ZU;2-9
Abstract
OBJECTIVE: To evaluate the use and potential benefit of famotidine in the m anagement of schizophrenia. DATA SOURCES: Clinical literature accessed through MEDLINE (February 1998-O ctober 1998). Key search terms included famotidine, schizophrenia, and hist amine. DATA SYNTHESIS: Schizophrenia is a complicated disorder associated with hig h morbidity if left unmanaged. Histamine(2) (H-2)-antagonists may be an alt ernative to conventional treatments. An evaluation of studies focusing on f amotidine in the management of schizophrenic symptoms was conducted. CONCLUSIONS: Famotidine can improve schizophrenic symptoms that were otherw ise refractory to typical antipsychotic agents. Further studies should be c onducted to determine if other H-2-antagonists are also effective.